RxDoctor Payments Data

Norma Green, MD

Family Medicine · Atchison, KSNPI 1548437544

Payments from drug & device makers

$1,813in general payments, 2019–2025

Across 115 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$375
  • Lilly USA, LLC$149
  • Amgen$119
  • Astellas Pharma US Inc$101
  • Pfizer$100
  • AstraZeneca$95
  • plus $874 from 28 others

What the payments were for

  • Food & beverage$1,809100%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,813 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$5,132
Medicare patients
36
Services billed
61

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$57,894
XifaxanRifaximin11$36,014
OxycontinOxycodone Hcl32$34,528
EliquisApixaban46$25,170
JardianceEmpagliflozin35$24,064
TrulicityDulaglutide20$19,607
ByettaExenatide13$11,660
JanuviaSitagliptin Phosphate18$10,142
SymbicortBudesonide/Formoterol Fumarate31$9,924
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$7,239
FarxigaDapagliflozin Propanediol12$6,511
Lantus SolostarInsulin Glargine,hum.Rec.Anlog63$6,427
Pregabalin67$4,483
ArexvyRsvpref3 Antigen/As01e/Pf11$3,207
Oxycodone Hcl181$3,197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$77$57,89453 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$61$36,01411 claims
AstraZenecaByetta, Symbicort, Farxiga$95$28,09556 claims
PfizerEliquis$100$25,17046 claims
Boehringer IngelheimJardiance$40$24,06435 claims
Lilly USA, LLCTrulicity$149$19,60720 claims
GSKArexvy, Shingrix$46$5,35722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Atchison

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →